Gene · 5166
Papers3,136
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 3,136
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of RNA methyltransferase METTL3 in gynecologic cancers: Results and mechanisms. | Front Pharmacol | 2023 | 37007040 | PubTator, text mining | PubMed |
| Acori Tatarinowii Rhizoma: A comprehensive review of its chemical composition, pharmacology, pharmacokinetics and toxicity. | Front Pharmacol | 2023 | 37007031 | PubTator, text mining | PubMed |
| LCZ696 (sacubitril/valsartan) inhibits pulmonary hypertension induced right ventricular remodeling by targeting pyruvate dehydrogenase kinase 4. | Biomed Pharmacother | 2023 | 37001183 | PubTator, text mining | PubMed |
| Inhibition of lncRNA PCAT19 promotes breast cancer proliferation. | Cancer Med | 2023 | 36992525 | PubTator, text mining | PubMed |
| PROTAC'ing oncoproteins: targeted protein degradation for cancer therapy. | Mol Cancer | 2023 | 36991452 | PubTator, text mining | PubMed |
| Adropin Predicts Chronic Kidney Disease in Type 2 Diabetes Mellitus Patients with Chronic Heart Failure. | J Clin Med | 2023 | 36983232 | PubTator, text mining | PubMed |
| Pyruvate Dehydrogenase Kinase 4 Deficiency Increases Tumorigenesis in a Murine Model of Bladder Cancer. | Cancers (Basel) | 2023 | 36980540 | PubTator, text mining | PubMed |
| Chemotherapy-Induced Molecular Changes in Skeletal Muscle. | Biomedicines | 2023 | 36979884 | PubTator, text mining | PubMed |
| The Role of miRNAs in Neuropathic Pain. | Biomedicines | 2023 | 36979754 | PubTator, text mining | PubMed |
| Inhibition of Pyruvate Dehydrogenase in the Heart as an Initiating Event in the Development of Diabetic Cardiomyopathy. | Antioxidants (Basel) | 2023 | 36979003 | PubTator, text mining | PubMed |
| Microbiome-Metabolome Reveals the Contribution of the Gut-Testis Axis to Sperm Motility in Sheep (Ovis aries). | Animals (Basel) | 2023 | 36978536 | PubTator, text mining | PubMed |
| Metabolic dysfunction-associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment. | J Physiol Biochem | 2023 | 36976456 | PubTator, text mining | PubMed |
| Enhanced Ca2+-channeling complex formation at the ER-mitochondria interface underlies the pathogenesis of alcohol-associated liver disease. | Nat Commun | 2023 | 36973273 | PubTator, text mining | PubMed |
| Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma. | Nat Commun | 2023 | 36973268 | PubTator, text mining | PubMed |
| The deubiquitinating enzyme 13 retards non-alcoholic steatohepatitis via blocking inactive rhomboid protein 2-dependent pathway. | Acta Pharm Sin B | 2023 | 36970206 | PubTator, text mining | PubMed |
| VEGF-B hypertrophy predisposes to transition from diastolic to systolic heart failure in hypertensive rats. | Cardiovasc Res | 2023 | 36951047 | PubTator, text mining | PubMed |
| ALDOC- and ENO2- driven glucose metabolism sustains 3D tumor spheroids growth regardless of nutrient environmental conditions: a multi-omics analysis. | J Exp Clin Cancer Res | 2023 | 36945054 | PubTator, text mining | PubMed |
| Emerging role of exosomes in vascular diseases. | Front Cardiovasc Med | 2023 | 36937921 | PubTator, text mining | PubMed |
| Identification of anoikis-related molecular patterns to define tumor microenvironment and predict immunotherapy response and prognosis in soft-tissue sarcoma. | Front Pharmacol | 2023 | 36937870 | PubTator, text mining | PubMed |
| Feeding-induced hepatokines and crosstalk with multi-organ: A novel therapeutic target for Type 2 diabetes. | Front Endocrinol (Lausanne) | 2023 | 36936164 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5166/papers?page=27